Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by U. Andergassen
The HER2 Phenotype of Circulating Tumor Cells in HER2-positive Early Breast Cancer: A Translational Research Project of a Prospective Randomized Phase III Trial
PLoS ONE
Multidisciplinary
Related publications
Effects of Herceptin on Circulating Tumor Cells in HER2 Positive Early Breast Cancer
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy® System in Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
The Impact of HER2 Phenotype of Circulating Tumor Cells in Metastatic Breast Cancer: A Retrospective Study in 107 Patients
BMC Cancer
Cancer Research
Oncology
Genetics
Optimal Treatment of Early Stage HER2-positive Breast Cancer
Cancer
Cancer Research
Oncology
A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations
Journal of Medical Genetics
Genetics
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Optimizing the Management of HER2-positive Early Breast Cancer: The Clinical Reality
Current Oncology
Oncology
Efficacy and Safety of CT-P6 Versus Reference Trastuzumab in HER2-positive Early Breast Cancer: Updated Results of a Randomised Phase 3 Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Dual HER2 Blockade Versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal of Oncology
Oncology
